These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24570763)

  • 1. Inspiratory flows and volumes in subjects with cystic fibrosis using a new dry powder inhaler device.
    Elkins MR; Robinson P; Anderson SD; Perry CP; Daviskas E; Charlton B
    Open Respir Med J; 2014; 8():1-7. PubMed ID: 24570763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inspiratory Flows and Volumes in Subjects with Non-CF Bronchiectasis Using a New Dry Powder Inhaler Device.
    Elkins MR; Anderson SD; Perry CP; Daviskas E; Charlton B
    Open Respir Med J; 2014; 8():8-13. PubMed ID: 24570764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dry powder inhaler resistance on the inspiratory flow rates and volumes of cystic fibrosis patients of six years and older.
    Tiddens HA; Geller DE; Challoner P; Speirs RJ; Kesser KC; Overbeek SE; Humble D; Shrewsbury SB; Standaert TA
    J Aerosol Med; 2006; 19(4):456-65. PubMed ID: 17196074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin Dry Powder for Inhalation: Inspiratory Flow in Patients with Non-cystic Fibrosis Bronchiectasis.
    Stass H; Nagelschmitz J; Kappeler D; Sommerer K; Patzlaff A; Weimann B
    J Aerosol Med Pulm Drug Deliv; 2019 Jun; 32(3):156-163. PubMed ID: 30848695
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of human behavior on inspiratory flow profiles in patients with pulmonary arterial hypertension using AOS™ dry powder inhaler device.
    Sahay S; Holy R; Lyons S; Parsley E; Maurer M; Weers J
    Pulm Circ; 2021; 11(1):2045894020985345. PubMed ID: 33532060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inspiratory flow patterns with dry powder inhalers of low and medium flow resistance in patients with pulmonary arterial hypertension.
    Faria-Urbina M; Ung KT; Lawler L; Zisman LS; Waxman AB
    Pulm Circ; 2021; 11(2):20458940211012591. PubMed ID: 34035895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peak inspiratory flow generated through different analogue dry powder inhalers in Shenzhen healthy preschool children].
    Zhang QL; Zheng JP; Pan WH; He H; Chen GL; An JY; Yuan LF; Luo DF
    Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):98-103. PubMed ID: 19099680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD.
    Chetta A; Yorgancioglu A; Scuri M; Barile S; Guastalla D; Dekhuijzen PNR
    BMC Pulm Med; 2021 Feb; 21(1):65. PubMed ID: 33632183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prerequisites for a dry powder inhaler for children with cystic fibrosis.
    Lexmond AJ; Hagedoorn P; Frijlink HW; Rottier BL; de Boer AH
    PLoS One; 2017; 12(8):e0183130. PubMed ID: 28800360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung characteristics in elderly males and females patients with COPD: differences and optimal use of dry powder inhalers (DPIs).
    Terzano C; Oriolo F
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2708-2716. PubMed ID: 28678314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Use of Easyhaler
    Kainu A; Vartiainen VA; Mazur W; Hisinger-Mölkänen H; Lavorini F; Janson C; Andersson M
    Pulm Ther; 2024 Mar; 10(1):133-142. PubMed ID: 38170393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inspiratory flow rate through a dry powder inhaler (Clickhaler) in children with asthma.
    Parry-Billings M; Birrell C; Oldham L; O'Callaghan C
    Pediatr Pulmonol; 2003 Mar; 35(3):220-6. PubMed ID: 12567391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Prevalence of Suboptimal Peak Inspiratory Flow in Hospitalized Patients With COPD: A Real-world Study.
    Mahler DA; Demirel S; Hollander R; Gopalan G; Shaikh A; Mahle CD; Elder J; Morrison C
    Chronic Obstr Pulm Dis; 2022 Jul; 9(3):427-438. PubMed ID: 35788259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder.
    Gauani H; Baker T; Li Z; Malinin VS; Perkins WR; Sullivan EJ; Cipolla D
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma.
    Amirav I; Newhouse MT; Mansour Y
    Pediatr Pulmonol; 2005 May; 39(5):447-51. PubMed ID: 15765541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhalation of tobramycin using simulated cystic fibrosis patient profiles.
    Haynes A; Geller D; Weers J; Ament B; Pavkov R; Malcolmson R; Debonnett L; Mastoridis P; Yadao A; Heuerding S
    Pediatr Pulmonol; 2016 Nov; 51(11):1159-1167. PubMed ID: 27133552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the Effectiveness of Written Dry Powder Inhaler Instructions and Health Literacy in Subjects Diagnosed With COPD.
    Alsomali HJ; Vines DL; Stein BD; Becker EA
    Respir Care; 2017 Feb; 62(2):172-178. PubMed ID: 28028187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peak Inspiratory Flow Measured at Different Inhaler Resistances in Patients with Asthma.
    Haughney J; Lee AJ; McKnight E; Pertsovskaya I; O'Driscoll M; Usmani OS
    J Allergy Clin Immunol Pract; 2021 Feb; 9(2):890-896. PubMed ID: 33011302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of inhaled dry-powder mannitol in adults with cystic fibrosis: An international, randomized controlled study.
    Flume PA; Amelina E; Daines CL; Charlton B; Leadbetter J; Guasconi A; Aitken ML
    J Cyst Fibros; 2021 Nov; 20(6):1003-1009. PubMed ID: 33715994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.